Oxygen concentrators are widely used to treat patients with deficient supply of oxygen or who lack adequate amount of oxygen in blood. This device can be operated by being plugged into an energy source or using batteries. Oxygen concentrators are better alternative to oxygen cylinders that are heavy to carry everywhere. Oxygen concentrators can either be fixed devices or portable. Therefore, these devices can also be used at home. However, a prescription from a registered physician is required to purchase oxygen concentrators. Patients with severe respiratory disorders (asthma, nocturnal hypoxemia, terminal malignancy, and hypoxia) and cardiovascular diseases are prescribed oxygen concentrators. Moreover, oxygen concentrators are widely used in military or in case of disasters where carrying/using oxygen tanks could be risky due to its highly combustible nature.
The increasing number of surgeries is expected to offer lucrative growth opportunities for players in the global medical oxygen concentrators market. Generally oxygen is provided to patients at the time of surgery to prevent or treat acute hypoxaemia. For instance, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, admissions for emergency surgery increased between 2016-2017 and 2017-2018 by 2.9% in public hospitals and by 5.1% in private hospitals in Australia.
- This report provides in-depth analysis of the global medical oxygen concentrators market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period 2025-2032, considering 2024 as the base year.
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global medical oxygen concentrators market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Inogen Inc., Invacare Corporation, OxygenToGo, LLC, Koninklijke Philips N.V., ResMed Inc., Drive DeVilbiss Healthcare LLC, Precision Medical, Inc., Besco Medical Co. Ltd., O2 Concepts, LLC, and GCE Group.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global medical oxygen concentrators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global medical oxygen concentrators market.
-
-
- Pulse Flow
- Continuous Flow
-
- Hospital
- Home Care
- Ambulatory Surgical Centers
-
- North America
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
-
- Inogen Inc.
- Invacare Corporation
- OxygenToGo, LLC
- Koninklijke Philips N.V.
- ResMed Inc.
- Drive DeVilbiss Healthcare LLC
- Precision Medical, Inc.
- Besco Medical Co. Ltd.
- O2 Concepts, LLC
- GCE Group
